William Mackenzie

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials

Clinical Pharmacology & Therapeutics · 2017 · 70 citations

Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States

The International Journal of Tuberculosis and Lung Disease · 2013 · Last of 13 authors · 66 citations